Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
Reply to @johnN: Fidelity Select Biotechnology fund and T. Rowe Price Health Sciences fund are each up 75% since 2007, thanks to big gains in health care and biotech stocks.
Reply to @johnN: In 2012 we switched from Bill Gross PTTRX to its ETF, BOND. So far so good, at least the portfolio is more transparent even at $4 billion asset.
Comments
bill gross pimco total return etf first yr
http://www.kiplinger.com/article/investing/T022-C009-S003-pimco-total-return-etf-first-year.html
sail against the winds
http://www.vanguard.com/us/insights/article/economic-week-review-02152013
http://www.usatoday.com/story/money/personalfinance/2013/02/18/stock-funds-pass-2007-highs/1928147/